Blood pressure response to standing in the diagnosis of autonomic neuropathy: The EURODIAB IDDM Complications Study

Archives of Physiology and Biochemistry

Volumn 109, Issue 3 SPEC ISS., 2001, Pages 215-222

  Kempler, P ^a   Tesfaye, S ^b   Chaturvedi, N ^c   Stevens, L K ^c   Webb, D J ^c   Eaton, S ^b   Kerenyi Zs ^d   Tamas Gy ^a   Ward, J D ^b   Fuller, J H ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Szent Imre Hospital   (Hungary)

Author keywords

Autonomic neuropathy; Blood pressure; Blood pressure response to standing; Cardiovascular autonomic neuropathy; Diabetic neuropathy; Orthostatic hypotension; Type 1 diabetes mellitus

Indexed keywords

ADOLESCENT; ADULT; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR REFLEX; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEUROPATHY; FAINTNESS; FEMALE; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; STANDING;

ADOLESCENT; ADULT; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; POSTURE; RISK FACTORS;

EID: 18644376563     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.109.3.215.11589     Document Type: Conference Paper

References (31)

1. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK for the EURODIAB IDDM Complications Study Group (1995): Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38: 437-444.
2. American Diabetes Association, American Academy of Neurology: Consensus statement (1988): Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11: 592-596.
3. Aronson D (1997): Pharmacologic modulation of autonomic tone: implications for the diabetic patient. Diabetologia 40: 476-481.
4. Bloom S, Till S, Sonksen P, Smith S (1984): Use of a biothesiometer to measure individual vibration threshold and their variation in 519 non-diabetic. Br Med J 288: 1793-1795.
5. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996): Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46: 1470.
6. Eichorst H (1892): Beiträge zur Pathologie der Nerven und Muskeln. Archiv Pathol Anat Physiol Klin Med 127: 1-17.
7. EURODIAB IDDM Complications Study Group (1994): Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285.
8. Ewing DJ, Campbell IW, Burt AA, Clarke BF (1973): Vascular reflexes in diabetic autonomic neuropathy. Lancet II: 1354-1356.
9. Ewing DJ, Clarke BF (1982): Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285: 916-918.
10. Hendrickse, MT, Thuluvath, PJ, Triger, DR (1992): The natural history of autonomic neuropathy in chronic liver disease. Lancet 339: 1462-1464.
11. Gambardella S, Frontoni S, Spallone V, Maiello MR, Civetta E, Lanza G, Menzinger G (1993): Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 6: 97-102.
12. Jermendy Gy (1995): Sympathovagal balance and cardiovascular diseases in diabetic patients with autonomic neuropathy. Diab Nutr Metab 8: 123-124.
13. Jermendy Gy, Ferenczy J, Hernandez E, Farkas K, Nádas J (1996): Day-night blood pressure variation in normotensive and hypertensive MDDM patients with asymptomatic autonomic neuropathy. Diabetes Res Clin Pract 34: 107-114.
14. Jermendy G, Tóth L, Vörös P, Koltay MZ, Pogátsa G (1990): QT-interval in diabetic autonomic neuropathy. Diabet Med 7: 750.
15. Kempler P, Hermányi Zs, Keresztes K, Marton A (1998b): Klinische und prognostische Bedeutung der kardialen autonomen Neuropathie. In: Gries FA, Federlin K, eds., Benfotiamin in der Therapie von Polyneuropathien. Thieme Verlag, Stuttgart-New York, pp. 39-44.
16. Kempler P, Keresztes K, Hermányi Zs, Marton A (1998a): Studies must establish whether prolonged QTc interval in newly diagnosed type 1 diabetes is reversible. Br Med J 317: 678-679.
17. Kempler P, Váradi A, Szalay F (1992): Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet 340: 318.
18. Kempler P, Váradi A, Szalay F, Tamás Gy (1994): Autonomic neuropathy and corrected QT interval prolongation: there is a relationship. Diabetes Care 17: 454-456.
19. Kempler P, Váradi A, Tamás G (1993): Autonomic neuropathy in newly diagnosed diabetes mellitus. Diabetes Care 16: 848-849.
20. Mathias CJ (1997): Autonomic disorders and their recognition. N Engl J Med 336: 721-724.
21. Palatini P, Julius S (1997): Heart rate and the cardiovascular risk. J Hypertens 15: 3-17.
22. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45: 801-805.
23. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G (1994): Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 17: 578-584.
24. Stephenson JM, Kempler P, Cavallo Perin P, Fuller JH (1996): Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 39: 1372-1376.
25. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD and the EURODIAB IDDM Study Group (1996): Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39: 1377-1384.
26. Vinik AI, Zola BE (1995): The effects of diabetic autonomic neuropathy on the cardiovascular system. In: Schwartz CJ, Born GVR, eds., New horizons in diabetes mellitus and cardiovascular disease. Current Science Ltd, London, UK. pp. 159-171.
27. Wheeler T, Watkins PJ (1973): Cardiac denervation in diabetes. Br Med J IV: 584-586.
28. Wieling W, Smit AAJ, Karemaker JM (1997): Diabetic autonomic neuropathy: conventional cardiovascular laboratory testing and new developments. Neurosci Res Commun 21: 67-74.
29. Ziegler D (1994): Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment. Diabetes Metab Rev 10: 339-383.
30. Ziegler D, Dannehl K, Spüler M, Mühlen H, Gries, FA (1992): Prevalence of cardiovascular autonomic nerve dysfunction assessed by spectral analysis and standard tests of heart rate variation in newly diagnosed IDDM patients. Diabetes Care 15: 908-911.
31. 123I] metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia 41: 443-451.